Overall Technical outlook

Price Summary

On 2026-07-01, GLAXO's stock opened at 2476.8, reached a peak of 2504.7, dropped to 2426.8, and ended -0.49% down at 2464.7, with a volume of 133980 shares.
The stock's highest price over the 52-week span is 3309.0, while the lowest price is 2103.2.

Technicals

Support and Resistance: With the current price at 2464.7, support is found at 2459.8 and resistance at 2699.3. These levels indicate where buyers might step in at 2459.8, while sellers could limit gains at 2699.3, defining a trading boundary for GlaxoSmithKline Pharmaceuticals Limited.
GLAXO supportResistance 01f5c5
Support/Resistance for GLAXO


Aroon: The bullish trend in Aroon remains, with Aroon Up consistently at the 100 level. This points to sustained upward momentum, but the trend should be explored further alongside other indicators to better understand its implications.
GLAXO aroon 01f5c5
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO bbands 01f5c5
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help sustain the market's upward movement. This strong support suggests that GlaxoSmithKline Pharmaceuticals Limited is likely to continue trending higher, providing investors with confidence in the ongoing bullish momentum.
GLAXO psar 01f5c5
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The stochastic indicator signals a bullish outlook, with the K-line above the D-line and the 80 threshold. This configuration points to strong upward momentum, implying that the market may continue to rise. Investors might see this as a positive indication of potential upward movement.
GLAXO stoch 01f5c5
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLAXO trippleSMA 01f5c5
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.